Ihsane Hmamouchi
@epirheum.bsky.social
Clinical Epidemiologist & Rheumatologist | 🧘🏽♀️Yoga lover |http://EpiRheum.com
Trying to Ask good questions and Measure what’s really matters 🌟
Trying to Ask good questions and Measure what’s really matters 🌟
🌍 Wrapped up the #GlobalHealth module with Master students @UIR university of rabat!
We explored health #literacy, #digital access, & the U.S. withdrawal from WHO, sparking insightful debates & fresh perspectives.
👏 Well done to all & looking forward where your ideas take you next!
We explored health #literacy, #digital access, & the U.S. withdrawal from WHO, sparking insightful debates & fresh perspectives.
👏 Well done to all & looking forward where your ideas take you next!
February 5, 2025 at 9:50 PM
🌍 Wrapped up the #GlobalHealth module with Master students @UIR university of rabat!
We explored health #literacy, #digital access, & the U.S. withdrawal from WHO, sparking insightful debates & fresh perspectives.
👏 Well done to all & looking forward where your ideas take you next!
We explored health #literacy, #digital access, & the U.S. withdrawal from WHO, sparking insightful debates & fresh perspectives.
👏 Well done to all & looking forward where your ideas take you next!
Reposted by Ihsane Hmamouchi
🚨 The CDC just pulled all BRFSS data & documentation offline, along with other datasets. This is a huge loss for public health research.
What does it mean? Why does it matter?
Here's what I learned from using BRFSS for one of my first studies: pubmed.ncbi.nlm.nih.gov/32541614/
What does it mean? Why does it matter?
Here's what I learned from using BRFSS for one of my first studies: pubmed.ncbi.nlm.nih.gov/32541614/
February 1, 2025 at 1:51 AM
🚨 The CDC just pulled all BRFSS data & documentation offline, along with other datasets. This is a huge loss for public health research.
What does it mean? Why does it matter?
Here's what I learned from using BRFSS for one of my first studies: pubmed.ncbi.nlm.nih.gov/32541614/
What does it mean? Why does it matter?
Here's what I learned from using BRFSS for one of my first studies: pubmed.ncbi.nlm.nih.gov/32541614/
📢 Honored to share at #SFR24 our study on a tailored benchmark index for Arabic-language rheumatology awareness campaigns.
🗣️An approach addressing dialectal diversity and working with low-resource data to drive impactful insights.
A big thank you to our incredible team 🤩
#ArabicDataInsights
🗣️An approach addressing dialectal diversity and working with low-resource data to drive impactful insights.
A big thank you to our incredible team 🤩
#ArabicDataInsights
December 10, 2024 at 11:10 PM
📢 Honored to share at #SFR24 our study on a tailored benchmark index for Arabic-language rheumatology awareness campaigns.
🗣️An approach addressing dialectal diversity and working with low-resource data to drive impactful insights.
A big thank you to our incredible team 🤩
#ArabicDataInsights
🗣️An approach addressing dialectal diversity and working with low-resource data to drive impactful insights.
A big thank you to our incredible team 🤩
#ArabicDataInsights
New NEJM article explores Target Trial Emulation—a method to align observational studies with RCT principles.
While promising for reducing bias, it depends on robust data and careful design.
A powerful tool, but no substitute for RCTs.
www.nejm.org/doi/full/10....
#Epidemiology #Biostatistics
While promising for reducing bias, it depends on robust data and careful design.
A powerful tool, but no substitute for RCTs.
www.nejm.org/doi/full/10....
#Epidemiology #Biostatistics
“Target Trial Emulation” for Observational Studies — Potential and Pitfalls | NEJM
To improve the quality of observational studies, target trial emulation requires careful specification of design elements, analytic methods for addressing confounding, and reporting of sensitivity ...
www.nejm.org
November 24, 2024 at 7:21 AM
New NEJM article explores Target Trial Emulation—a method to align observational studies with RCT principles.
While promising for reducing bias, it depends on robust data and careful design.
A powerful tool, but no substitute for RCTs.
www.nejm.org/doi/full/10....
#Epidemiology #Biostatistics
While promising for reducing bias, it depends on robust data and careful design.
A powerful tool, but no substitute for RCTs.
www.nejm.org/doi/full/10....
#Epidemiology #Biostatistics
That’s a wrap! From Marrakech 🇲🇦 to Belo Horizonte 🇧🇷
At the 20th #ICUH in Marrakech, UIR-IPORA One Health panel 😊
Insights ranged from salutogenic landscapes to global-local approaches for healthier cities.
fostering collaboration to build resilient urban futures!!
#OneHealth #UrbanHealth
At the 20th #ICUH in Marrakech, UIR-IPORA One Health panel 😊
Insights ranged from salutogenic landscapes to global-local approaches for healthier cities.
fostering collaboration to build resilient urban futures!!
#OneHealth #UrbanHealth
November 23, 2024 at 8:19 AM
That’s a wrap! From Marrakech 🇲🇦 to Belo Horizonte 🇧🇷
At the 20th #ICUH in Marrakech, UIR-IPORA One Health panel 😊
Insights ranged from salutogenic landscapes to global-local approaches for healthier cities.
fostering collaboration to build resilient urban futures!!
#OneHealth #UrbanHealth
At the 20th #ICUH in Marrakech, UIR-IPORA One Health panel 😊
Insights ranged from salutogenic landscapes to global-local approaches for healthier cities.
fostering collaboration to build resilient urban futures!!
#OneHealth #UrbanHealth
Superbe expérience 🥰
And the global networking continues. If you are attending an international conference, you can use that time to have a meal with your colleagues from around the world. This is part of rheumatology.
#ACR24
#ACR24
November 17, 2024 at 10:17 AM
Superbe expérience 🥰
Reposted by Ihsane Hmamouchi
🤍🤍🤍🤍🤍🤍
And the global networking continues. If you are attending an international conference, you can use that time to have a meal with your colleagues from around the world. This is part of rheumatology.
#ACR24
#ACR24
November 17, 2024 at 4:27 AM
🤍🤍🤍🤍🤍🤍